Clinical Trial Results: Safety and Efficacy Study of Inhaled Carbon Monoxide to Treat Acute Respiratory Distress Syndrome (ARDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing inhaled carbon monoxide for safety and efficacy in treating acute respiratory distress syndrome (ARDS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Inhaled carbon monoxide (carbon monoxide inhalation)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Acute Respiratory Distress Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2026-06-16